Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited15.806117032225.5841
Domestic EquitiesMax Healthcare Institute Limited6.15431185469.9614
Domestic EquitiesLupin Limited6.0519595169.7957
Domestic EquitiesDr. Reddy's Laboratories Limited5.3729140178.6966
Domestic EquitiesMankind Pharma Limited5.0581346278.1872
Domestic EquitiesApollo Hospitals Enterprise Limited4.7544129407.6955
Domestic EquitiesSuven Pharmaceuticals Limited4.40751080197.1341
Domestic EquitiesDivi's Laboratories Limited4.1354167246.6936
Domestic EquitiesZydus Lifesciences Limited3.6218614795.8623
Domestic EquitiesLaurus Labs Limited2.92681052734.7373
Domestic EquitiesCipla Limited2.4144279143.9080
Domestic EquitiesSyngene International Limited2.4081565593.8978
Domestic EquitiesTorrent Pharmaceuticals Limited2.2349136893.6174
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.2083187613.5744
Domestic EquitiesAlembic Pharmaceuticals Limited2.0218327383.2725
Domestic EquitiesFDC Limited1.9573698693.1682
Domestic EquitiesIPCA Laboratories Limited1.8943228913.0662
Domestic EquitiesPiramal Pharma Limited1.83962072852.9776
Domestic EquitiesHealthcare Global Enterprises Limited1.8017796702.9163
Domestic EquitiesOrchid Pharma Limited1.6348245322.6461
Domestic EquitiesArchean Chemical Industries Limited1.5272379002.4720
Domestic EquitiesVijaya Diagnostic Centre Limited1.5150350642.4522
Domestic EquitiesAjanta Pharma Limited1.249091252.0216
Domestic EquitiesCaplin Point Laboratories Limited1.2367147582.0018
Domestic EquitiesJupiter Life Line Hospitals Limited1.2302161341.9912
Domestic EquitiesAurobindo Pharma Limited1.1570162361.8728
Domestic EquitiesRainbow Childrens Medicare Limited1.0860127831.7579
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.054581791.7068
Domestic EquitiesSanofi India Limited1.004019521.6251
Domestic EquitiesVishnu Chemicals Limited0.9955524271.6113
Domestic EquitiesFortis Healthcare Limited0.9739359461.5764
Domestic EquitiesMetropolis Healthcare Limited0.966486051.5642
Domestic EquitiesAbbott India Limited0.95585851.5471
Domestic EquitiesSequent Scientific Limited0.94991243391.5375
Domestic EquitiesAstec LifeSciences Limited0.9327117541.5097
Domestic EquitiesShilpa Medicare Limited0.9219271131.4922
Domestic EquitiesGland Pharma Limited0.845880001.3690
Domestic EquitiesStrides Pharma Science Limited0.8193148001.3262
Domestic EquitiesSumitomo Chemical India Limited0.7918319531.2816
Domestic EquitiesSun Pharma Advanced Research Company Limited0.7642532441.2369
Total 99.6812 161.3458
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.3188 0.5160
Total 0.3188 0.5160
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.